Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
35.30
+0.92 (2.68%)
Dec 31, 2025, 12:08 PM HKT

HKG:2315 Statistics

Total Valuation

HKG:2315 has a market cap or net worth of HKD 23.58 billion. The enterprise value is 23.73 billion.

Market Cap23.58B
Enterprise Value 23.73B

Important Dates

The next estimated earnings date is Wednesday, March 25, 2026.

Earnings Date Mar 25, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2315 has 446.90 million shares outstanding. The number of shares has decreased by -0.31% in one year.

Current Share Class 110.78M
Shares Outstanding 446.90M
Shares Change (YoY) -0.31%
Shares Change (QoQ) -0.38%
Owned by Insiders (%) 14.07%
Owned by Institutions (%) 18.99%
Float 150.85M

Valuation Ratios

The trailing PE ratio is 96.73 and the forward PE ratio is 90.63.

PE Ratio 96.73
Forward PE 90.63
PS Ratio 18.07
PB Ratio 24.01
P/TBV Ratio 24.60
P/FCF Ratio 63.55
P/OCF Ratio 55.89
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 57.43, with an EV/FCF ratio of 63.94.

EV / Earnings 163.79
EV / Sales 18.18
EV / EBITDA 57.43
EV / EBIT 102.42
EV / FCF 63.94

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.69.

Current Ratio 1.89
Quick Ratio 1.51
Debt / Equity 0.69
Debt / EBITDA 1.50
Debt / FCF 1.81
Interest Coverage 3.26

Financial Efficiency

Return on equity (ROE) is 16.11% and return on invested capital (ROIC) is 10.77%.

Return on Equity (ROE) 16.11%
Return on Assets (ROA) 6.20%
Return on Invested Capital (ROIC) 10.77%
Return on Capital Employed (ROCE) 12.10%
Revenue Per Employee 999,222
Profits Per Employee 110,932
Employee Count1,117
Asset Turnover 0.48
Inventory Turnover 33.60

Taxes

In the past 12 months, HKG:2315 has paid 19.10 million in taxes.

Income Tax 19.10M
Effective Tax Rate 11.65%

Stock Price Statistics

The stock price has increased by +320.24% in the last 52 weeks. The beta is 0.09, so HKG:2315's price volatility has been lower than the market average.

Beta (5Y) 0.09
52-Week Price Change +320.24%
50-Day Moving Average 29.60
200-Day Moving Average 22.35
Relative Strength Index (RSI) 63.82
Average Volume (20 Days) 1,937,097

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2315 had revenue of HKD 1.30 billion and earned 144.88 million in profits. Earnings per share was 0.36.

Revenue1.30B
Gross Profit 1.04B
Operating Income 267.32M
Pretax Income 163.97M
Net Income 144.88M
EBITDA 419.11M
EBIT 267.32M
Earnings Per Share (EPS) 0.36
Full Income Statement

Balance Sheet

The company has 533.47 million in cash and 673.00 million in debt, giving a net cash position of -139.54 million or -0.31 per share.

Cash & Cash Equivalents 533.47M
Total Debt 673.00M
Net Cash -139.54M
Net Cash Per Share -0.31
Equity (Book Value) 982.46M
Book Value Per Share 2.45
Working Capital 458.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 421.96 million and capital expenditures -50.86 million, giving a free cash flow of 371.09 million.

Operating Cash Flow 421.96M
Capital Expenditures -50.86M
Free Cash Flow 371.09M
FCF Per Share 0.83
Full Cash Flow Statement

Margins

Gross margin is 79.48%, with operating and profit margins of 20.48% and 11.10%.

Gross Margin 79.48%
Operating Margin 20.48%
Pretax Margin 12.56%
Profit Margin 11.10%
EBITDA Margin 32.12%
EBIT Margin 20.48%
FCF Margin 28.44%

Dividends & Yields

HKG:2315 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.31%
Shareholder Yield 0.31%
Earnings Yield 0.61%
FCF Yield 1.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2315 has an Altman Z-Score of 1.4 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.4
Piotroski F-Score 7